Skip to main content
. Author manuscript; available in PMC: 2016 Mar 15.
Published in final edited form as: Clin Cancer Res. 2015 Jan 14;21(6):1447–1456. doi: 10.1158/1078-0432.CCR-14-1773

Table 1.

Cohort description table

Gender
male 19
female 10
Age at diagnosis of nodal metastasis
in years (median; range)
74; 48–92
Immune status
immunocompromised 4
not immunocompromised 25
Smoking
yes 12
no 17
Recurrence
yes 11
no 18
Received radiation therapy
yes 6
no 23
Prior diagnosis of cSCC
yes 12
no 17
Progression-free survival
in months (median; range)
37; 1–130
Overall survival
in months (median; range)
60; 7–155